Sotera Health Company (MUN:SH5)
14.20
+0.10 (0.71%)
At close: Dec 5, 2025
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2019 - 2020 |
| United States Revenue | - | 616.68M |
Log In |
Log In |
Log In | Upgrade
|
| Canada Revenue | - | 208.89M |
Log In |
Log In |
Log In | Upgrade
|
| Europe Revenue | - | 196.01M |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographic Revenue | - | 78.86M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 1.15B | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 1.15B | 1.10B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2019 - 2020 |
| Sterigenics Revenue | 736.80M | 697.85M |
Log In |
Log In |
Log In | Upgrade
|
| Nordion Revenue | 194.58M | 173.36M |
Log In |
Log In |
Log In | Upgrade
|
| Nelson Labs Revenue | 219.00M | 229.23M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 1.15B | 1.10B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2019 - 2020 |
| Service Revenue | 975.51M | 941.82M |
Log In |
Log In |
Log In | Upgrade
|
| Product Revenue | 174.87M | 158.62M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 1.15B | 1.10B |
Log In |
Log In |
Log In | Upgrade
|
Adjusted EBITDA
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2019 - 2020 |
| Sterigenics Segment Income | 402.49M | 378.17M |
Log In |
Log In |
Log In | Upgrade
|
| Nordion Segment Income | 114.23M | 101.22M |
Log In |
Log In |
Log In | Upgrade
|
| Nelson Labs Segment Income | 72.98M | 69.18M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | -245.90M | -250.95M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 343.80M | 297.63M |
Log In |
Log In |
Log In | Upgrade
|
Capital Expenditures
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2019 - 2020 |
| Sterigenics Capital Expenditures | 112.15M | 131.26M |
Log In |
Log In |
Log In | Upgrade
|
| Nordion Capital Expenditures | 26.75M | 34.93M |
Log In |
Log In |
Log In | Upgrade
|
| Nelson Labs Capital Expenditures | 14.28M | 12.88M |
Log In |
Log In |
Log In | Upgrade
|